Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IDH1 R132H peptide vaccine |
Trade Name | |
Synonyms | |
Drug Descriptions |
IDH1 R132H peptide vaccine is a cancer vaccine comprising a peptide that includes the IDH1 R132H mutation, which may increase immune response against tumor cells harboring IDH1 R132H, resulting in decreased tumor growth (PMID: 25043048). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + IDH1 R132H peptide vaccine | Avelumab IDH1 R132H peptide vaccine | 0 | 1 |
IDH1 R132H peptide vaccine | IDH1 R132H peptide vaccine | 1 | 1 |